Skye Bioscience (SKYE) Receivables - Affiliates (2022)

Skye Bioscience (SKYE) posted quarterly Receivables - Affiliates of $22542.0 for Q3 2022, up 78.13% quarter-over-quarter from $12655.0 in Q2 2022.

Skye Bioscience (SKYE) Receivables - Affiliates (2022) Analysis & Trends

Skye Bioscience (SKYE) has reported Receivables - Affiliates for 1 consecutive years, with $22542.0 the latest figure, recorded in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables - Affiliates (Qtr)
1	Vertex Pharmaceuticals	140.29 Bn	132.43 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.58 Bn	78.58 Bn	3.93 Bn	-
3	Argenx Se	65.26 Bn	60.08 Bn	1.37 Bn	-
4	Moderna	61.87 Bn	56.73 Bn	52.00 Mn	-
5	BeOne Medicines	42.18 Bn	37.08 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.51 Bn	28.20 Bn	992.69 Mn	-
7	BioNTech SE	28.90 Bn	10.51 Bn	668.28 Mn	-
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	-
9	Royalty Pharma	27.24 Bn	26.41 Bn	-	-
10	Skye Bioscience	10.72 Mn	10.72 Mn	-	-

Download Data